(Press-News.org) Washington, D.C., March 31, 2014 ― Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP®) Lipid Panel showed the impact high-density lipoprotein (HDL) cholesterol and remnant lipoprotein (RLP) cholesterol have on determining a patient's risk for hard coronary heart disease (CHD) endpoints, such as myocardial infarction or coronary death. Each analysis examined men and women without prevalent CHD enrolled in both the Framingham Offspring and Jackson Heart studies over eight years. In both studies, HDL, the "good" cholesterol in the body and RLP, similar to the "bad" cholesterol in the body (low-density lipoprotein, or LDL) – levels were measured by the VAP® Lipid Panel, the most accurate and comprehensive lipid profile available to assess cardiometabolic risk. While previous study findings have shown the link between HDL and CHD, results from the meta-analyses determined that HDL subfractions, specifically HDL3, were much more predictive in assessing and reducing a patient's risk for CHD, while RLP cholesterol was associated with increasing a patient's risk. Data from both studies were presented via poster at the 2014 Annual Meeting of the American College of Cardiology (ACC) in Washington, D.C.
"With a significant relationship between HDL, RLP and hard CHD events, these findings are a critical step forward in helping physicians develop a better understanding of the relationship between lipoproteins and cardiovascular risk," said Dr. Steven R. Jones, investigator and Director of Inpatient Cardiology at Johns Hopkins Hospital as well as faculty of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease in Baltimore.
The first meta-analysis examined HDL cholesterol subfractions, specifically HDL2 (cholesterol removal) and HDL3 (cholesterol distribution), and the risk for CHD. HDL2 is responsible for removing cholesterol from the bloodstream while HDL3 is responsible for the distribution of cholesterol. In previous studies throughout the world, HDL cholesterol has been negatively correlated with risk for CHD; however, the relationship between HDL subfractions and CHD is much more controversial. Findings from the study revealed a significant correlation between HDL cholesterol as well as HDL3 cholesterol risk for incident hard CHD events. For each tertile increase in HDL cholesterol and HDL3 cholesterol, there was a 25 percent and 28 percent reduction in risk for hard CHD, respectively. Despite this connection, HDL2 cholesterol did not achieve statistically significant results related to reducing risk of CHD.
The second meta-analysis reviewed RLP on hard CHD events. Remnants are precursors to LDL and can be elevated if there is impaired triglyceride lipid breakdown as observed in patients with metabolic syndrome and diabetes. Results showed that LDL cholesterol and non-HDL cholesterol demonstrated significant relationships with hard CHD risk. In addition, intermediate-density lipoprotein (IDL), which enables fat and cholesterol to move within the bloodstream, and RLP cholesterol were also highly correlated with increasing risk for hard CHD. For each tertile rise in IDL cholesterol and RLP cholesterol, there was a 41 percent and 37 percent increase in risk for hard CHD, respectively.
Atherotech also presented additional data from The Jackson Heart study via poster on March 29, 2014. For more information on Atherotech or the VAP® Lipid Panel, visit http://www.Atherotech.com.
INFORMATION:
About Atherotech and the VAP®+ Lipid Panel
Atherotech Diagnostics Lab is a leading clinical reference laboratory specializing in cardiometabolic testing and disease management solutions. Atherotech's proprietary and comprehensive VAP®+ Lipid Panel enables clinicians to accurately stratify a patient's cardiovascular risk and deliver personalized treatment strategies to improve health outcomes. The Vertical Auto Profile (VAP+) technology reveals residual cardiometabolic risk as recommended in the NCEP ATP III, ADA/ACC Joint Consensus and AACE guidelines. The VAP+ utilizes direct measurement to identify cholesterol, triglyceride and genetic lipid disorders. The company's dedication to affordable, comprehensive disease management solutions includes Our Healthy Heart™, a patient consultation program and expert lipid management education service to health care providers. For more information, please visit http://www.Atherotech.com or call 1-866-VAP-TEST.
For information on the VAP+ Lipid Panel and Atherotech Diagnostics Lab, visit http://www.Atherotech.com or call 877-901-8510. Health care professionals interested in real cases from the trenches of lipidology may visit http://www.CobblesCorner.com, Atherotech's official blog. Atherotech is on Twitter at http://www.twitter.com/Atherotech, on Facebook at http://www.facebook.com/Atherotech, and broadcasting at http://www.YouTube.com/user/VAPatherotech.
Data show benefit of comprehensive lipid testing in determining risk for coronary heart disease
Findings presented at the American College of Cardiology Annual Meeting using the VAP Lipid Panel highlight connection between lipoproteins and risk of coronary heart disease
2014-03-31
ELSE PRESS RELEASES FROM THIS DATE:
Giving steroids during bypass surgery shows no benefit, some harm
2014-03-31
WASHINGTON (March 31, 2014) — Giving patients steroids at the time of heart surgery does not improve health outcomes and appears to put them at greater risk of having a heart attack in the days following surgery, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. The finding, which stems from the largest randomized trial in cardiac surgery ever conducted, challenges a practice that many surgeons have used for decades.
"Based on these results, we suggest that steroids should not be used prophylactically during cardiac ...
Metformin fails to reduce heart failure after heart attack
2014-03-31
Washington (March 31, 2014) — The use of metformin, a common regulator of blood glucose for diabetics, does not help protect against heart failure in non-diabetic patients who have suffered a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
The GIPS-III trial is the first double-blind, randomized, placebo-controlled study conducted to evaluate whether four months of metformin treatment preserved left ventricular function in non-diabetic patients with acute myocardial infarction.
Metformin is commonly ...
Bariatric surgery beats medical therapy alone for managing diabetes
2014-03-31
WASHINGTON (March 31, 2014) — Gastric bypass and sleeve gastrectomy – two of the most commonly used bariatric surgeries – are more effective than intensive medical therapy alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after three years, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.
STAMPEDE is the largest randomized controlled trial with one of the longest follow-ups to compare the effect of these two procedures to intensive medical therapy in helping patients achieve ...
'Ivory tower' bucking social media
2014-03-31
EAST LANSING, Mich. — University scholars are largely resisting the use of social media to circulate their scientific findings and engage their tech-savvy students, a Michigan State University researcher argues in a new paper.
While social media is widely used in fields such as journalism and business – not just to push a product but also to engage in open dialogue with readers and clients – it has failed to take hold in academia's so-called ivory tower. This is troubling given that universities in the United States and Europe are trying to increase access to publicly ...
Can vitamin A turn back the clock on breast cancer?
2014-03-31
(PHILADELPHIA) – A derivative of vitamin A, known as retinoic acid, found abundantly in sweet potato and carrots, helps turn pre-cancer cells back to normal healthy breast cells, according to research published this month in the International Journal of Oncology. The research could help explain why some clinical studies have been unable to see a benefit of vitamin A on cancer: the vitamin doesn't appear to change the course of full-blown cancer, only pre-cancerous cells, and only works at a very narrow dose.
Because cells undergo many changes before they become fully ...
Excessive hospital occupancy levels result in avoidable mortality
2014-03-31
Once a hospital reaches a certain occupancy level, the quality of care it provides deteriorates, increasing the risk of mortality of critically ill patients. What is worrying is that this safety 'tipping point' is reached at occupancy levels that are below 100%. The findings are reported by a team of researchers led by Ludwig Kuntz, Professor of Health Management at the University of Cologne. Their paper (Stress on the Ward: Evidence of Safety Tipping Points in Hospitals) is to appear shortly in the international journal Management Science.
For the purposes of their study, ...
Anesthetic technique important to prevent damage to brain
2014-03-31
Researchers at the University of Adelaide have discovered that a commonly used anesthetic technique to reduce the blood pressure of patients undergoing surgery could increase the risk of starving the brain of oxygen.
Reducing blood pressure is important in a wide range of surgeries – such as sinus, shoulder, back and brain operations – and is especially useful for improving visibility for surgeons, by helping to remove excess blood from the site being operated on.
There are many different techniques used to lower patients' blood pressure for surgery – one of them is ...
Minneapolis Cardiology Fellow named an ACCF Young Investigators Awards finalist
2014-03-31
MINNEAPOLIS, MN – March 31, 2014 – Minneapolis Heart Institute Chief Cardiology Fellow Ankur Kalra, MD has been named as a finalist for the 2014 ACCF Young Investigators Awards. Kalra's research, funded by the Minneapolis Heart Institute Foundation (MHIF), supports the ongoing quest to better identify, with noninvasive tools, which heart attack survivors are at greatest risk for sudden cardiac death, and therefore may benefit from ICD (implantable cardioverter defibrillator) therapy. Kalra will present his research at the American College of Cardiology (ACC) meeting in ...
Can gratitude reduce costly impatience?
2014-03-31
The human mind tends to devalue future rewards compared to immediate ones – a phenomenon that often leads to favoring immediate gratification over long-term wellbeing. As a consequence, patience has long been recognized to be a virtue. And indeed, the inability to resist temptation underlies a host of problems ranging from credit card debt and inadequate savings to unhealthy eating and drug addiction.
The prevailing view for reducing costly impatience has emphasized the use of willpower. Emotions were to be tamped down in order to avoid irrational impulses for immediate ...
Periodic puns: Chemistry jokes just in time for April Fools' Day (video)
2014-03-31
WASHINGTON, March 31, 2014 — It's almost April Fools' Day, and the American Chemical Society's (ACS') Reactions video series is celebrating with an episode featuring our favorite chemistry jokes. Which two elements look cute together? Why is father water concerned about his "iced out" son? What do you get when you combine sulfur, tungsten and silver? Get all the punchlines in the latest Reactions episode, available at: http://youtu.be/C5RZRkhk0OM.
Subscribe to the series at Reactions YouTube, and follow us on Twitter @ACSreactions.
INFORMATION:
The American Chemical ...
LAST 30 PRESS RELEASES:
Novel SOURCE study examining development of early COPD in ages 30 to 55
NRL completes development of robotics capable of servicing satellites, enabling resilience for the U.S. space infrastructure
Clinical trial shows positive results for potential treatment to combat a challenging rare disease
New research shows relationship between heart shape and risk of cardiovascular disease
Increase in crisis coverage, but not the number of crisis news events
New study provides first evidence of African children with severe malaria experiencing partial resistance to world’s most powerful malaria drug
Texting abbreviations makes senders seem insincere, study finds
Living microbes discovered in Earth’s driest desert
Artemisinin partial resistance in Ugandan children with complicated malaria
When is a hole not a hole? Researchers investigate the mystery of 'latent pores'
ETRI, demonstration of 8-photon qubit chip for quantum computation
Remote telemedicine tool found highly accurate in diagnosing melanoma
New roles in infectious process for molecule that inhibits flu
Transforming anion exchange membranes in water electrolysis for green hydrogen production
AI method can spot potential disease faster, better than humans
A development by Graz University of Technology makes concreting more reliable, safer and more economical
Pinpointing hydrogen isotopes in titanium hydride nanofilms
Political abuse on X is a global, widespread, and cross-partisan phenomenon, suggests new study
Reintroduction of resistant frogs facilitates landscape-scale recovery in the presence of a lethal fungal disease
Scientists compile library for evaluating exoplanet water
Updated first aid guidelines enhance care for opioid overdose, bleeding, other emergencies
Revolutionizing biology education: Scientists film ‘giant’ mimivirus in action
Genetic variation enhances cancer drug sensitivity
Protective genetic mutation offers new hope for understanding autism and brain development
Colombia's Dr. Natalia Acosta-Baena uncovers critical link between brain development and degeneration
How can we reduce adolescent pregnancies in low- and middle-income countries?
When sun protection begets malnutrition: vitamin D deficiency in Japanese women
Cannabis use can cause chromosomal damage, increasing cancer risk and harming offspring
Survey finds many Americans apply misguided and counterproductive advice to combat holiday weight gain
New study reveals half a century of change on Britain’s iconic limestone pavements
[Press-News.org] Data show benefit of comprehensive lipid testing in determining risk for coronary heart diseaseFindings presented at the American College of Cardiology Annual Meeting using the VAP Lipid Panel highlight connection between lipoproteins and risk of coronary heart disease